CFHR3 is a potential novel biomarker for hepatocellular carcinoma

  title={CFHR3 is a potential novel biomarker for hepatocellular carcinoma},
  author={Jinlong Liu and Wenli Li and Hetong Zhao},
  journal={Journal of Cellular Biochemistry},
  pages={2970 - 2980}
Complement factor H‐related 3 (CFHR3) is a protein‐coding gene acting in various diseases. However, its prognostic values of CFHR3 in hepatocellular carcinoma (HCC) are not understandable. Therefore, we present a further study on CFHR3 in HCC. CFHR3 expression data were acquired from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC). We compared the differential expression of CFHR3 between the low‐stage (stage I and II) and high‐stage (stage III and IV… Expand
“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Derangement of specific complement proteins in HCC is reviewed in the context of altered complement regulatory factors, immune-activating components, and their implications in disease pathogenesis. Expand
Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
A random forest classifier was established that identified 10 core genes in HB that may be beneficial for the diagnosis, prediction, and targeted therapy of HB. Expand
Identification of potential core genes in hepatoblastoma via bioinformatics analysis
DEGs and hub genes identified in the present study help to understand the molecular mechanisms underlying the carcinogenesis and progression of hepatoblastoma, and provide candidate targets for diagnosis and treatment of hepatOBlastoma. Expand
Identification of significant potential signaling pathways and differentially expressed proteins in patients with wheat intolerance based on quantitative proteomics.
  • Wei Zhang, Lin Sun, +6 authors Qiuju Zhang
  • Medicine
  • Journal of proteomics
  • 2021
This study identified significant signaling pathways and differentially expressed proteins in patients with wheat intolerance by means of bioinformatics from the viewpoint of mass spectrometry-based proteomics, which provided insights into further research on the pathogenesis and timely diagnosis of wheat intolerance. Expand


The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma
The AP2M1 level showed excellent prognosis predictions in comparison with existing markers in the three independent cohorts and was more predictive of prognosis than other markers in alcohol intake and HCV infections. Expand
SAC3D1: a novel prognostic marker in hepatocellular carcinoma
SAC3D1 overexpression was associated with poor prognosis of HCC with good discriminative ability in 3 independent cohorts and multivariate analysis confirmed its prognostic significance. Expand
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
Investigation of the role of ADAMTSL4 at transcriptome level and its relationship with clinical practice in glioblastoma multiforme found that it was enriched in GBM (WHO grade IV), especially for those with IDH1/2 wild-type and MGMT unmethylated groups. Expand
Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases
The results of the present study suggest that the overexpression of UBE2C may be used as a novel prognostic biomarker of HCC. Expand
Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy.
The CFHR3,1Δ genotype did not associate with progression toward CKD stages 3 and 5 in the white population of patients with IgAN, although it did associate with a reduced level of glomerular immune deposits. Expand
Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1.
The data demonstrate the unprecedented role of complement proteins on the maintenance of stemness in liver tumor-initiating cells and find that LSF-1 is involved in this regulation. Expand
Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma
Inhibition of PD-L1+ ICs and TGF-β activity and their respective immunomodulatory pathways may contribute to antitumor effects in HCC. Expand
High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
It is revealed that the aHUS-risk haplotype CFH(H3)–CFHR3*B– CFHR1*B generates twofold more FHR-3 than the non-risk CFH (H1)– CF HR3*A–CF HR1*A haplotype and CFHR3-3 levels were higher in patients with aH US than in control individuals with the same CFHR2 genotype. Expand
HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas
The database HCCDB is developed to serve as a one-stop online resource for exploring HCC gene expression with user-friendly interfaces and provides links to third-party databases on drug, proteomics, and literatures, and graphically displays the results from computational analyses. Expand
Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma
It is found that RB depletion in hepatoma cells resulted in a compromised immunological response to multiple stimuli and reduced the potential of these cells to recruit myeloid cells, which confirmed that RB participates in the regulation of innate immunity in liver parenchymal cells both in vitro and in vivo. Expand